EPZM Epizyme Inc
Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.
$10.19 -0.22 (-2.11%)
As of 02/24/2021 15:59:53 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
05/31/2013
101,581,358
834,866
$1,057,461,937
0.00%
SEC Edgar Online
10-Q
10-K
29428V104
US29428V1044
B9Z1QZ7
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
05/31/2013
101,581,358
834,866
$1,057,461,937
0.00%
SEC Edgar Online
10-Q
10-K
29428V104
US29428V1044
B9Z1QZ7
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-4.75
5.06
90.53
-90.78%
-1,899.35%
5.06
90.53
-90.78%
-1,899.35%